These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33755901)

  • 1. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
    Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
    Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
    Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
    Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
    Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
    Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling.
    Namipashaki A; Pugsley K; Liu X; Abrehart K; Lim SM; Sun G; Herold MJ; Polo JM; Bellgrove MA; Hawi Z
    Stem Cell Reports; 2023 Dec; 18(12):2515-2527. PubMed ID: 37977144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.
    Molugu K; Khajanchi N; Lazzarotto CR; Tsai SQ; Saha K
    CRISPR J; 2023 Oct; 6(5):473-485. PubMed ID: 37676985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
    Thamodaran V; Rani S; Velayudhan SR
    Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.
    Simkin D; Papakis V; Bustos BI; Ambrosi CM; Ryan SJ; Baru V; Williams LA; Dempsey GT; McManus OB; Landers JE; Lubbe SJ; George AL; Kiskinis E
    Stem Cell Reports; 2022 Apr; 17(4):993-1008. PubMed ID: 35276091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs.
    Zhang JP; Yang ZX; Zhang F; Fu YW; Dai XY; Wen W; Zhang B; Choi H; Chen W; Brown M; Baylink D; Zhang L; Qiu H; Wang C; Cheng T; Zhang XB
    Sci China Life Sci; 2021 Sep; 64(9):1449-1462. PubMed ID: 33420926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
    Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
    Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells.
    Brandão KO; Grandela C; Yiangou L; Mummery CL; Davis RP
    Methods Mol Biol; 2022; 2454():531-557. PubMed ID: 33755904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Monoclonal iPSC Lines with Stable Cas9 Expression and High Cas9 Activity.
    Liao JQ; Zhou G; Zhou Y
    Methods Mol Biol; 2022; 2454():575-588. PubMed ID: 32567018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.